Home/Filings/4/0001020741-25-000004
4//SEC Filing

JONES EVAN/ FA 4

Accession 0001020741-25-000004

CIK 0001384101other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 4:10 PM ET

Size

24.4 KB

Accession

0001020741-25-000004

Insider Transaction Report

Form 4
Period: 2025-11-05
Transactions
  • Sale

    Common Stock

    2025-11-05$45.07/sh5,872$264,64055,421 total
  • Exercise/Conversion

    Common Stock

    2025-11-05$5.28/sh+10,000$52,80053,664 total
  • Exercise/Conversion

    Common Stock

    2025-11-05$7.94/sh+10,000$79,40063,664 total
  • Exercise/Conversion

    Common Stock

    2025-11-05$7.60/sh+10,000$76,00073,664 total
  • Sale

    Common Stock

    2025-11-05$41.74/sh408$17,03173,256 total
  • Sale

    Common Stock

    2025-11-05$43.03/sh1,126$48,45572,130 total
  • Sale

    Common Stock

    2025-11-05$43.80/sh10,837$474,70261,293 total
  • Sale

    Common Stock

    2025-11-05$46.38/sh657$30,46930,468 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-0510,0000 total
    Exercise: $5.28Exp: 2026-06-20Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-0510,0000 total
    Exercise: $7.94Exp: 2027-06-07Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-0510,0000 total
    Exercise: $7.60Exp: 2028-06-07Common Stock (10,000 underlying)
  • Sale

    Common Stock

    2025-11-05$45.73/sh24,296$1,110,99031,125 total
Footnotes (8)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 9, 2024.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $41.10 to $41.97. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $42.285 to $43.20. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]Represents weighted average sales price. Sale prices for the transactions range from $43.29 to $44.29. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F5]Represents weighted average sales price. Sale prices for the transactions range from $44.335 to $45.335. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F6]Represents weighted average sales price. Sale prices for the transactions range from $45.34 to $44.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F7]Represents weighted average sales price. Sale prices for the transactions range from $46.35 to $46.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F8]The option is fully vested.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001020741

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:10 PM ET
Size
24.4 KB